Electra Therapeutics, Inc. (ETRA)

Electra Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Electra Therapeutics Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-86.75	-61.89	-26.32
Net Income	-95.2	-61.98	-24.79

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	97.73	86.52	15.79
Total Debt	1.98	2.09	0
Net Cash (Debt)	95.74	84.43	15.79
Net Cash Growth	-	434.88%	-

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-74.68	-60.48	-26
Capital Expenditures	-0.64	-0.73	-
Free Cash Flow	-75.32	-61.22	-26
Free Cash Flow Growth	-	-	-